Key clinical point: While women with COPD have more anxiety and dyspnea than do men, mortality rates between the sexes are similar.
Major finding: Gender did not affect mortality over 3 years since levels were nearly identical (at 11.2% for men and 10.8% for women).
Study details: Mortality and survival analysis of 177 women and 458 men with COPD matched by age and FEV1 level.
Disclosures: The cohort is supported by Boehringer Ingelheim France and (until 2015) Pfizer. No other study funding is reported. The study authors report multiple and various disclosures.
Zysman M et al. Respir Res. 2019 Aug 22.